PLATELET INDICES AND LIVER FIBROSIS EVALUATION IN CHRONIC HEPATITIS C

Insights

Platelet indices like mean platelet volume and platelet distribution width can indicate advanced liver fibrosis in chronic hepatitis C patients. These findings suggest their utility in assessing liver fibrosis severity non-invasively.

Area of Science:

  • Hepatology
  • Hematology
  • Diagnostic Biomarkers

Background:

  • Chronic hepatitis C is a significant cause of liver fibrosis.
  • Platelet indices have emerged as potential indicators of liver fibrosis severity.
  • Non-invasive methods for assessing liver fibrosis are crucial for patient management.

Purpose of the Study:

  • To investigate the correlation between platelet indices and liver fibrosis stages.
  • To evaluate the diagnostic value of mean platelet volume (MPV), platelet large cell ratio (P-LCR), and platelet distribution width (PDW) in chronic hepatitis C.
  • To compare these indices with liver fibrosis assessment by transient elastography.

Main Methods:

  • Prospective enrollment of 139 patients with chronic hepatitis C.
  • Simultaneous assessment of complete blood count parameters and liver fibrosis using transient elastography.
  • Statistical analysis comparing platelet indices (MPV, P-LCR, PDW) with fibrosis stages.

Main Results:

  • Patients with advanced liver fibrosis showed significantly increased MPV (p < 0.002), P-LCR (P < 0.0001), and PDW (P = 0.003) compared to those with mild/moderate fibrosis.
  • A total of 139 patients were included, with 70.5% males and a mean age of 54.8 years.
  • The study utilized SPSS 17.0 for statistical analysis, with P < 0.05 considered significant.

Conclusions:

  • Elevated platelet indices are associated with advanced liver fibrosis in chronic hepatitis C.
  • Platelet indices may serve as valuable non-invasive biomarkers for assessing liver fibrosis severity.
  • Transient elastography is a reliable method for staging liver fibrosis in conjunction with platelet indices.
Abstract